Thyrocare Technologies Ltd approved amendments to its Code of Conduct under SEBI regulations and reported its Q2 2025 financial results. The company also appointed a new CFO and noted the resignation of a director, both effective July 23, 2025, with additional changes starting July 24, 2025.